IRIS
VIGNERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.585
EU - Europa 3.747
AS - Asia 2.885
SA - Sud America 648
AF - Africa 407
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.332
SG - Singapore 1.401
IT - Italia 1.394
CN - Cina 789
IE - Irlanda 764
BR - Brasile 599
UA - Ucraina 571
IN - India 394
DE - Germania 280
CI - Costa d'Avorio 242
CA - Canada 233
RU - Federazione Russa 168
SN - Senegal 112
NL - Olanda 105
BE - Belgio 101
GB - Regno Unito 79
SE - Svezia 65
VN - Vietnam 65
FI - Finlandia 57
KR - Corea 52
CZ - Repubblica Ceca 34
BD - Bangladesh 31
FR - Francia 29
UZ - Uzbekistan 21
CH - Svizzera 20
AR - Argentina 19
JP - Giappone 19
PL - Polonia 19
NG - Nigeria 18
GR - Grecia 15
IQ - Iraq 14
IR - Iran 14
AT - Austria 13
ES - Italia 12
MX - Messico 12
TR - Turchia 12
IL - Israele 10
LB - Libano 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
PK - Pakistan 8
ZA - Sudafrica 8
CO - Colombia 7
KE - Kenya 7
OM - Oman 6
SA - Arabia Saudita 6
TN - Tunisia 6
AU - Australia 5
BG - Bulgaria 5
HK - Hong Kong 5
VE - Venezuela 5
AZ - Azerbaigian 4
EU - Europa 4
JO - Giordania 4
PY - Paraguay 4
RS - Serbia 4
AL - Albania 3
EG - Egitto 3
CR - Costa Rica 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
GA - Gabon 1
GL - Groenlandia 1
HU - Ungheria 1
ID - Indonesia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.283
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.346
Singapore 903
Chandler 840
Dublin 764
Jacksonville 646
Chicago 509
Catania 371
Kochi 337
Boardman 331
Abidjan 242
Cambridge 206
Lawrence 203
Nanjing 200
Andover 193
Toronto 156
Ashburn 146
Grafing 134
Dakar 112
Des Moines 111
Hefei 111
San Mateo 100
Civitanova Marche 98
Wilmington 86
Munich 63
New York 57
Ottawa 54
Rotterdam 54
Palermo 52
Nanchang 51
Seoul 51
Wingene 50
Milan 48
Hebei 47
Rome 46
Shenyang 45
São Paulo 42
Los Angeles 41
Dong Ket 40
Saint Petersburg 38
Beijing 36
Bremen 34
Brussels 34
Portland 33
The Dalles 32
Council Bluffs 31
Seattle 31
Changsha 30
Columbus 30
Jiaxing 30
Brno 28
Falls Church 26
Tianjin 26
Bari 25
Turku 25
San Giovanni la Punta 23
Rio de Janeiro 22
Moscow 19
Tokyo 19
Abuja 18
Hanoi 17
Pune 17
San Francisco 17
Belo Horizonte 16
Helsinki 16
Messina 16
Quintano 16
Lappeenranta 15
Brasília 14
Florence 14
Houston 14
Jinan 14
Aci Catena 13
Bernareggio 13
Frankfurt Am Main 13
Santa Venerina 13
Augusta 12
Brooklyn 12
Curitiba 11
Dhaka 11
Hangzhou 11
Kunming 11
Leawood 11
Nijmegen 11
Norwalk 11
Woodbridge 11
Ardabil 10
Atlanta 10
Giarre 10
Gioiosa Marea 10
Ningbo 10
Verona 10
Zhengzhou 10
Izegem 9
Mascalucia 9
Siracusa 9
Warsaw 9
Guangzhou 8
Liberty Lake 8
Manchester 8
Miami 8
Totale 9.964
Salva come PNG Salva come JPEG
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 192
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 156
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications 118
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 115
Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review 111
Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release 110
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 108
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 104
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 104
Diagnostic utility of the immunohistochemical expression of serin and arginine rich splicing factor 1 (Srsf1) in the differential diagnosis of adult gliomas 104
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas 101
Biomarkers and prognostic factors for malignant pleural mesothelioma 100
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 98
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 95
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 93
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series 91
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 91
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 90
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein 88
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND FUNCTION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS 87
Comparative proteomic analysis of insulin receptor isoform A and B signaling 86
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 86
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 86
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 85
New insights in thyroid cancer and p53 family proteins 85
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 85
BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells 83
Heavy metals in the volcanic environment and thyroid cancer 82
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE 81
BCR-Abl tyrosine kinase activity modulates the expression of Interferon Regulatory Factor-5 in CML cells 81
BCR-ABL tyrosine kinase activity modulates the phosphorylation and the localization of Interferon Regulatory Factor 5 (IRF-5)in Chronic Myeloid Leukemia cells 81
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 80
Unsuccessful dasatinib therapy in a refractory patient with chronic lymphocytic leukemia 80
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 80
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 80
Uncommon long-term survival in a patient with chronic myeloid leukemia 79
Computational and Experimental Characterization of Two Nuclear Localization Signals and a Nuclear Export Signal that modulate BCR intracellular localization 79
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations 79
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 79
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 79
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND BIOLOGICAL FUNCTION OF INTERFERON REGULATORY FACTOR 5 IN CHRONIC MYELOID LEUKEMIA CELLS 78
Vg9Vd2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells 77
BCR-ABL tyrosine kinase activity modulates survivin expression via PI3K/AKT 77
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 76
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 76
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 76
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 76
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 75
c-IAP1, Survivin and Smac contribute to chemotherapy resistance in undifferentiated thyroid cancer cells 75
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 75
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 75
Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study 74
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 74
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma 73
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features 72
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 72
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 72
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 72
Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor 72
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 71
Hypoxia Induces Imatinib Resistance in CML Cell Lines 71
BCR-ABL tyrosine kinase activity modulates Survivin expression in CML cells 71
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 71
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 71
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 70
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 70
Several site-specific cancers are increased in the volcanic area in Sicily 69
FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series 69
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 68
The PU.1 transcription factor induces cyclin D2 expression in U937 cells 68
UNA INSERZIONE NEL DOMINIO TIROSIN-CHINASICO DI BCR-ABL POTREBBE CONTRIBUIRE ALLA RESISTENZA AD IMATINIB MESILATO DI PAZIENTI AFFETTI DA LEUCEMIA MIELOIDE CRONICA 68
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 68
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 68
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 68
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 68
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 68
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part II: treatment indications and complications 68
Histopathologic and mr imaging appearance of spontaneous and radiation-induced necrosis in uveal melanomas: Initial results 68
p73 tumor-suppressor activity is impaired in human thyroid cancer 67
Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients 66
Silencing of survivin induced by BCR-ABL/JAK2/STAT3 pathway kills CML cells and sensitizes IM-resistant clones to hydroxyurea 66
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 66
Insulin receptor isoforms in cancer 66
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 66
The p53-homologue p63 may promote thyroid cancer progression 65
Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib 65
BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B 65
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 65
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 64
Basal insulin and cardiovascular and other outcomes 64
BCR-ABL modifies the expression and function of the IRF-5 transcription factor 64
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 64
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 64
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase 63
Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL 63
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 63
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 62
Espressione e funzione di OMI/HTRA2 in tumori solidi ed ematologici 62
The optimal timing between neoadjuvant therapy and surgery of breast cancer: a brief systematic review of the literature 61
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors 61
Totale 7.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.253 16 91 140 15 304 36 136 6 233 4 185 87
2021/20221.496 155 202 22 20 229 37 223 49 136 28 56 339
2022/20232.775 228 144 58 296 208 462 32 540 633 20 94 60
2023/20241.443 108 220 52 78 76 257 34 86 10 67 268 187
2024/20255.951 159 869 311 258 1.148 686 255 185 364 460 780 476
2025/2026347 347 0 0 0 0 0 0 0 0 0 0 0
Totale 14.698